Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Benef Microbes ; 8(2): 257-269, 2017 Apr 26.
Article in English | MEDLINE | ID: mdl-28409534

ABSTRACT

There is a growing appreciation that our microbial environment in the gut plays a critical role in the maintenance of health and the pathogenesis of disease. Probiotic, beneficial gut microbes, administration can directly attenuate cardiac injury and post-myocardial infarction (MI) remodelling, yet the mechanisms of cardioprotection are unknown. We hypothesised that administration of Bifidobacterium animalis subsp. lactis 420 (B420), a probiotic with known anti-inflammatory properties, to mice will mitigate the pathological impact of MI, and that anti-inflammatory T regulatory (Treg) immune cells are necessary to impart protection against MI as a result of B420 administration. Wild-type male mice were administered B420, saline or Lactobacillus salivarius 33 (Ls-33) by gavage daily for 14 or 35 days, and underwent ischemia/reperfusion (I/R). Pretreatment with B420 for 10 or 28 days attenuated cardiac injury from I/R and reduced levels of inflammatory markers. Depletion of Treg cells by administration of anti-CD25 monoclonal antibodies eliminated B420-mediated cardio-protection. Further cytokine analysis revealed a shift from a pro-inflammatory to an anti-inflammatory environment in the probiotic treated post-MI hearts compared to controls. To summarise, B420 administration mitigates the pathological impact of MI. Next, we show that Treg immune cells are necessary to mediate B420-mediated protection against MI. Finally, we identify putative cellular, epigenetic and/or post-translational mechanisms of B420-mediated protection against MI.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Bifidobacterium animalis , Cardiotonic Agents/therapeutic use , Ligilactobacillus salivarius , Myocardial Infarction/therapy , Probiotics/therapeutic use , Animals , Dietary Supplements/microbiology , Inflammation/immunology , Inflammation/therapy , Male , Mice , Mice, Inbred C57BL , T-Lymphocytes, Regulatory/immunology
2.
Biochim Biophys Acta Mol Basis Dis ; 1863(6): 1464-1472, 2017 06.
Article in English | MEDLINE | ID: mdl-28192180

ABSTRACT

Aortic stenosis is known to involve inflammation and thrombosis. Changes in activity of extracellular enzyme - ecto-5'-nucleotidase (referred also as CD73) can alter inflammatory and thrombotic responses. This study aimed to evaluate the effect of CD73 deletion in mice on development of aortic valve dysfunction and to compare it to the effect of high-fat diet. Four groups of mice (normal-diet Wild Type (WT), high-fat diet WT, normal diet CD73-/-, high-fat diet CD73-/-) were maintained for 15weeks followed by echocardiographic analysis of aortic valve function, measurement of aortic surface activities of nucleotide catabolism enzymes as well as alkaline phosphatase activity, mineral composition and histology of aortic valve leaflets. CD73-/- knock out led to an increase in peak aortic flow (1.06±0.26m/s) compared to WT (0.79±0.26m/s) indicating obstruction. Highest values of peak aortic flow (1.26±0.31m/s) were observed in high-fat diet CD73-/- mice. Histological analysis showed morphological changes in CD73-/- including thickening and accumulation of dark deposits, proved to be melanin. Concentrations of Ca2+, Mg2+ and PO43- in valve leaflets were elevated in CD73-/- mice. Alkaline phosphatase (ALP) activity was enhanced after ATP treatment and reduced after adenosine treatment in aortas incubated in osteogenic medium. AMP hydrolysis in CD73-/- was below 10% of WT. Activity of ecto-adenosine deaminase (eADA), responsible for adenosine deamination, in the CD73-/- was 40% lower when compared to WT. Deletion of CD73 in mice leads to aortic valve dysfunction similar to that induced by high-fat diet suggesting important role of this surface protein in maintaining heart valve integrity.


Subject(s)
5'-Nucleotidase/deficiency , Aorta , Aortic Valve , Gene Deletion , Heart Valve Diseases , Animals , Aorta/metabolism , Aorta/pathology , Aorta/physiopathology , Aortic Valve/metabolism , Aortic Valve/pathology , Aortic Valve/physiopathology , Dietary Fats/adverse effects , Dietary Fats/pharmacology , Heart Valve Diseases/genetics , Heart Valve Diseases/metabolism , Heart Valve Diseases/pathology , Heart Valve Diseases/physiopathology , Mice , Mice, Knockout
3.
Ann R Coll Surg Engl ; 95(1): 9-14, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23317713

ABSTRACT

INTRODUCTION: Human donor organ shortages have led surgeons and scientists to explore the use of animals as alternative organ sources. Acute thrombovascular rejection (AVR) is the main hurdle in xenotransplantation. disparities in nucleotide metabolism in the vessels of different species may contribute significantly to the microvascular component of AVR. METHODS: We evaluated the extent of nucleotide metabolism mismatch in selected organs and endothelial cells of different mammals with particular focus on the changes in activity of ecto-5'-nucleotidase (E5'n) elicited by exposure of porcine hearts or endothelial cells to human blood (ex vivo) or human plasma (in vitro). RESULTS: E5'n activity in the rat heart was significantly higher than in other species. We noted a significant difference (p<0.001) in E5'n activity between human and pig endothelial cell lines. Initial pig aortic endothelial E5'n activity decreased in vitro after a three-hour exposure to human and porcine plasma while remaining constant in controls. ex vivo perfusion with fresh human blood for four hours resulted in a significant decrease of E5'n activity in both wild type and transgenic pig hearts overexpressing human decay accelerating factor (p<0.001). CONCLUSIONS: This study provides evidence that mismatches in basal mammalian metabolic pathways and humoral immunity interact in a xenogeneic environment. understanding the role of nucleotide metabolism and signalling in xenotransplantation may identify new targets for genetic modifications and may lead to the development of new therapies extending graft survival.


Subject(s)
5'-Nucleotidase/metabolism , Blood , Endothelial Cells/metabolism , Myocardium/enzymology , Animals , Animals, Genetically Modified , Cells, Cultured , Endothelium, Vascular/metabolism , Graft Survival , Humans , Immunity, Humoral/physiology , Papio , Purines/metabolism , Pyrimidines/metabolism , Rats , Species Specificity , Sus scrofa , Swine , Transplantation, Heterologous
4.
Transplant Proc ; 43(5): 1893-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21693296

ABSTRACT

A 53-year-old Caucasian male suffering from idiopathic dilated cardiomyopathy underwent cardiac transplantation. Fifty-seven days following transplant, he developed posttransplant lymphoproliferative disorder (PTLD), which was Epstein-Barr virus positive. The initial episode of PTLD was treated with a dose reduction in cyclosporine (CsA) and a 4-week course of rituximab. Subsequent biopsies showed resolution of PTLD. One year posttreatment, his evaluation revealed severe cardiac allograft vasculopathy (CAV). The patient was switched to sirolimus-based immunosuppression regimen with gradual up-titration of sirolimus in combination with complete withdrawal of previously administered Calcineurin-based immunosuppression approach. The switchover was carried out over a 6-week period. In the following 3 years, there was CAV regression as well as PTLD remission, without any significant episode of rejection. Despite frequent relapses with this form of PTLD, the patient remains in remission, 8 years posttransplantation. In summary, sirolimus has been demonstrated to attenuate the progression of CAV, and this case report illustrates that regression of CAV is possible. In addition to preventing rejection, mammalian target of rapamycin inhibitors directly suppress signaling pathways leading to PTLD and may be effective monotherapy for preventing rejection and suppressing PTLD.


Subject(s)
Antibodies, Monoclonal, Murine-Derived/therapeutic use , Cyclosporine/therapeutic use , Heart Transplantation/adverse effects , Lymphoproliferative Disorders/drug therapy , Antibodies, Monoclonal, Murine-Derived/administration & dosage , Calcineurin Inhibitors , Cyclosporine/administration & dosage , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Rituximab , Sirolimus/administration & dosage , Sirolimus/therapeutic use
5.
Emerg Med J ; 25(11): 777-8, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18955626

ABSTRACT

Dural sinus thrombosis (DST) has an annual incidence of 3-4 per million and can result from many aetiologies. Presentation of the disease can vary considerably, as can the aetiology and delay of symptoms to clinical detection. Symptoms on presentation include headache, seizures, focal neural deficits and altered mental status. There are many aetiological risk factors associated with DST, which include hypercoagulable states, oral contraceptive use, infection and mechanical causes such as cranial trauma. DST as a result of trauma is rare and aetiologies range from mechanical falls with or without skull fracture, firework explosions, gunshots to the head, blunt trauma to the head and closed head injury. Internal jugular vein thrombosis is also a rare disease and as with DST, traumatic aetiologies are uncommon. More common aetiologies include iatrogenic causes related to catheterisation as well as infectious causes (eg, Lemierre's syndrome). A case of thrombosis of the transverse sinus, sigmoid sinus and internal jugular vein associated with a closed head injury as the result of a motorcycle accident is presented.


Subject(s)
Accidents, Traffic , Head Injuries, Closed/complications , Sinus Thrombosis, Intracranial/etiology , Adult , Humans , Magnetic Resonance Angiography , Male , Motorcycles , Sinus Thrombosis, Intracranial/diagnosis , Tomography, X-Ray Computed
6.
Emerg Med J ; 25(9): 614-5, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18723725

ABSTRACT

Phrenic nerve palsy has previously been associated with brachial plexus root avulsion; severe unilateral phrenic nerve injury is not uncommonly associated with brachial plexus injury. Brachial plexus injuries can be traumatic (gunshot wounds, lacerations, stretch/contusion and avulsion injuries) or non-traumatic in aetiology (supraclavicular brachial plexus nerve block, subclavian vein catheterisation, cardiac surgeries, or obstetric complications such as birth palsy). Despite the known association, the incidence and morbidity of a phrenic nerve injury and hemidiaphragmatic paralysis associated with traumatic brachial plexus stretch injuries remains ill-defined. The incidence of an associated phrenic nerve injury with brachial plexus trauma ranges from 10% to 20%; however, because unilateral diaphragmatic paralysis often presents without symptoms at rest, a high number of phrenic nerve injuries are likely to be overlooked in the setting of brachial plexus injury. A case report is presented of a unilateral phrenic nerve injury associated with brachial plexus stretch injury presenting with a recalcitrant left lower lobe pneumonia.


Subject(s)
Brachial Plexus/injuries , Phrenic Nerve/injuries , Respiratory Paralysis/etiology , Accidents, Traffic , Adult , Humans , Male , Methicillin Resistance , Pneumonia, Bacterial/diagnostic imaging , Pneumonia, Bacterial/drug therapy , Pulmonary Atelectasis/diagnostic imaging , Respiratory Paralysis/diagnostic imaging , Staphylococcal Infections/diagnostic imaging , Staphylococcal Infections/drug therapy , Staphylococcus aureus , Tomography, X-Ray Computed , Ultrasonography
7.
Nucleosides Nucleotides Nucleic Acids ; 25(9-11): 1221-4, 2006.
Article in English | MEDLINE | ID: mdl-17065095

ABSTRACT

Xenotransplantation is one be possible solution for a severe shortage of human organs available for transplantation. However, only a few studies addressed metabolic compatibility of transplanted animal organs. Our aim was to compare activities of adenosine metabolizing enzymes in the heart of different species that are relevant to clinical or experimental xenotransplantation. We noted fundamental differences: ecto-5' nucleotidease (E5' N) activity was 4-fold lower in pig and baboon hearts compared to the human hearts while mouse activity was compatible with human and rat activity was three times higher than human. There also were significant differences in AMP-deaminase (AMPD), adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) activities. We conclude that differences in nucleotide metabolism may contribute to organ dysfunction after xenotransplantation.


Subject(s)
Heart Transplantation/methods , Nucleotides/chemistry , Transplantation, Heterologous/methods , 5'-Nucleotidase/biosynthesis , AMP Deaminase/biosynthesis , Adenosine/chemistry , Adenosine Deaminase/biosynthesis , Animals , Humans , Mice , Papio , Purine-Nucleoside Phosphorylase/biosynthesis , Rats , Species Specificity , Swine
8.
Article in English | MEDLINE | ID: mdl-16021912

ABSTRACT

We compared concentrations of nucleotide substrates and activities of enzymes of nucleotide metabolism in pig and human blood, heart, and kidney. The most important difference was lower ecto-5-nucleotidase (ESN) activity in both pig hearts and kidney. Furthermore, higher hypoxanthine, inosine, adenine, and uracil, but lower uridine and uric acid concentrations were observed in pig blood as compared to human. A twofold increase in UTP concentration has been observed in pig hearts following 4 h perfusion with human blood. Purine metabolism is an important target for genetic and pharmacological manipulation during xenotransplantations.


Subject(s)
Purines/metabolism , Transplantation, Heterologous/methods , 5'-Nucleotidase/metabolism , Adenosine Triphosphate/metabolism , Animals , Animals, Genetically Modified , Chromatography, High Pressure Liquid , Humans , Kidney/metabolism , Myocardium/metabolism , Species Specificity , Swine , Uridine Triphosphate/metabolism
9.
Article in English | MEDLINE | ID: mdl-16021914

ABSTRACT

Ecto-5'-nucleotidase (E5'N) is an extracellular enzyme forming anti-inflammatory and immunosuppressive adenosine. We evaluated whether confrontation of pig heart and endothelial cells with human blood changes the activity of E5'N. Pig hearts were perfused ex vivo with fresh human blood for 4 h. Pig aortic endothelial cells (PAEC) were incubated in vitro with human plasma for 3 h. Ex vivo perfusion of pig heart with fresh human blood resulted in a decrease in E5'N activity to 62% and 61% of initial in wild-type and transgenic pig hearts, respectively. PAEC activity of E5'N decreased to 71% and 50% of initial after 3 h exposure to heat-inactivated and active complement human plasma, respectively, while it remained constant in controls. Pig heart activity of E5'N decreased following exposure to human blood, which may affect adenosine production and exacerbate hyperacute and vascular rejection.


Subject(s)
5'-Nucleotidase/antagonists & inhibitors , 5'-Nucleotidase/metabolism , Blood/metabolism , Endothelium, Vascular/metabolism , Animals , Animals, Genetically Modified , Aorta/metabolism , Complement System Proteins , Endothelium, Vascular/cytology , Humans , Nucleotides/chemistry , Perfusion , Signal Transduction , Species Specificity , Swine , Time Factors , Transplantation, Heterologous
10.
Curr Pharm Des ; 10(32): 4121-6, 2004.
Article in English | MEDLINE | ID: mdl-15579092

ABSTRACT

The DNA mismatch repair system maintains genomic stability by correcting DNA sequence errors generated during DNA replication, during genetic exchanges between chromosomes i.e., recombination, and by correcting DNA lesions caused by mutagenic agents such as cis-platinum. Post-synthesis mismatch repair improves almost 1000-fold the fidelity of DNA replication; however, the functions of mismatch repair proteins extend well beyond DNA repair. Recent studies suggest that mismatch repair is part of the machinery that couples DNA damage and repair to cell cycle regulation and apoptosis. These studies indicate that tolerance to certain DNA lesions (such as methylation and cis-platinum adducts) is associated with inefficient activation of cell cycle checkpoints and inefficient activation of apoptosis in mismatch repair deficient cells. Hence, mismatch repair proteins regulate the survival threshold to DNA damage, and this function provides a novel platform for understanding the role of mismatch repair in B cells, in tumor formation, as well as in resistance to chemotherapy. In this communication, we review how mismatch repair may contribute to the physiology of cells and may be regulated by the intracellular trafficking of mismatch repair proteins.


Subject(s)
Base Pair Mismatch/physiology , DNA Damage/physiology , DNA Repair/physiology , Animals , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Apoptosis/drug effects , Cell Survival/drug effects , Humans , Neoplasms/drug therapy , Neoplasms/pathology
11.
Alcohol Clin Exp Res ; 20(5): 799-803, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8865951

ABSTRACT

After the consumption of ethanol, acetaldehyde levels increase in the serum, and the serum develops a nondialyzable cytotoxic activity caused by the formation of unstable acetaldehyde-albumin complexes. The concentration of acetaldehyde in the serum and the cytotoxic activity in serum albumin 8.5 hr after six healthy volunteers began to drink 94 g of ethanol were significantly less when the ethanol was consumed as red wine than as white wine. The serum acetaldehyde was measured by a fluorigenic HPLC assay, and the cytotoxic activity in albumin was determined using two different assays based on dissimilar endpoints: (1) detachment of adherent A9 cells and (2) impairment of the ability of A9 cells to reduce tetrazolium. When serum obtained from five other healthy volunteers after the consumption of white wine was incubated at 37 degrees C for 3 hr with a number of dietary antioxidants at a concentration of 100 mumol/liter, the cytotoxicity of the albumin was markedly reduced. The antioxidants studied consisted of six flavonoids (kaempherol, fisetin, quercetin catechin, taxifolin, and coumarin) and three nonflavonoids (salicylic acid, tannic acid, and alpha-tocopherol). In the cases of alpha-tocopherol, a statistically significant reduction of cytotoxicity was observed at a concentration of 10 mumol/liter. In addition, the cytotoxicity of artificially prepared acetaldehyde-albumin complexes was significantly reduced when such complexes were incubated with 50 to 100 mumol/liter of kaempherol, fisetin, quercetin, coumarin or salicylic acid, or 10 mumol/liter of alpha-tocopherol at 37 degrees C for 3 hr. Evidently, in vitro, flavonoid and nonflavonoid dietary constituents reduce the amount of unstable acetaldehyde-albumin complexes found in both postalcohol serum and in artificially produced acetaldehyde-albumin complexes. The difference in the amount of unstable acetaldehyde-albumin complexes found in serum after the consumption of red and white wine may therefore be caused by the higher concentration of antioxidants, including flavonoids, in red wine than in white wine. Because acetaldehyde and acetaldehyde-albumin complexes have been implicated in the pathogenesis of alcohol-mediated tissue damage, these data suggest that dietary antioxidants may influence the biological consequences of excess alcohol consumption.


Subject(s)
Acetaldehyde/pharmacokinetics , Antioxidants/pharmacology , Cell Survival/drug effects , Ethanol/pharmacokinetics , Flavonoids/pharmacology , Serum Albumin/metabolism , Vitamin E/pharmacology , Wine/adverse effects , Acetaldehyde/toxicity , Adult , Cell Line , Ethanol/toxicity , Humans , Hydrolyzable Tannins/pharmacology , Male , Salicylates/pharmacology , Salicylic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...